PAF C-18 (CAS 74389-69-8)

PAF C-18, a variant of platelet-activating factor (PAF), has garnered significant attention in scientific research for its role in elucidating cellular signaling pathways and physiological responses associated with PAF receptors. One key area of investigation involves studying the mechanisms of action by which PAF C-18 interacts with PAF receptors, particularly subtype 1 (PAF-R1), and modulates downstream intracellular signaling cascades. Research has revealed that PAF C-18 functions as a potent agonist or antagonist of PAF receptors, exerting diverse effects on cellular processes such as inflammation, immune response, and vascular permeability. Furthermore, studies have utilized PAF C-18 as a molecular tool to investigate the physiological and pathological roles of PAF receptors in various biological systems, including cardiovascular function, respiratory disorders, and neuroinflammation. Additionally, the development of PAF C-18 analogs and derivatives has facilitated the exploration of structure-activity relationships and optimization of pharmacological properties, offering insights into potential interventions targeting PAF receptor-mediated pathways. Overall, PAF C-18 remains a valuable asset in research aimed at understanding the complexities of PAF signaling and its implications in health and disease.